银屑病分层医学患者偏好:离散选择实验
本研究通过在线离散选择实验(DCE)调查英国212例银屑病成人对基于算法的生物制剂处方(「生物制剂计算器」)的偏好。受访者在六组假设选择集中从两个计算器方案和常规处方间选择,属性包括治疗延迟、阳性预测值、阴性预测值、感染风险和NHS成本节约。结果显示患者强烈偏好高预测准确性和避免严重感染,但两个样本间存在系统性偏好差异。
要点
- 银屑病患者重视生物制剂计算器的高预测准确性。
- 避免严重感染是患者偏好的重要属性。
- 不同来源样本的患者偏好存在系统性差异。
核心结论
- 银屑病患者会重视生物制剂计算器,且该计算器应具备足够准确性以预测未来应答和严重感染风险。
研究设计与样本
- 在线离散选择实验(DCE)纳入两个目的性样本的英国银屑病成人,分别来自银屑病协会(67人)和在线面板提供商Dynata(145人),共分析212名受访者数据。
主要发现
- 所有估计系数的符号与先验预期一致。
- 受访者强烈偏好高预测准确性和避免严重感染,但样本间存在系统性偏好差异。
关键数值与推荐
- DCE包含五个属性:治疗延迟、阳性预测值、阴性预测值、感染风险和NHS成本节约。
- 每位参与者从六组假设选择集中选出偏好方案。
- 采用条件logit和全相关随机参数logit模型分析选择数据。
临床怎么用
- 临床引入生物制剂计算器时应确保足够准确性以预测未来应答和严重感染风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: New technologies have enabled the potential for stratified medicine in psoriasis. It is important to understand patients' preferences to enable the informed introduction of stratified medicine, which is likely to involve a number of individual tests that could be collated into a prescribing algorithm for biological drug selection to be used in clinical practice. OBJECTIVES: To quantify patient preferences for an algorithm-based approach to prescribing biologics ('biologic calculator') in psoriasis. METHODS: An online survey comprising a discrete choice experiment (DCE) was conducted to elicit the preferences of two purposive samples of adults living with psoriasis in the UK, identified from a psoriasis patient organization (Psoriasis Association) and an online panel provider (Dynata). Respondents chose between two biologic calculators and conventional prescribing described using five attributes: treatment delay; positive predictive value; negative predictive value; risk of infection; and cost saving to the National Health Service. Each participant selected their preferred alternative from six hypothetical choice sets. Additional data, including sociodemographic characteristics, were collected. Choice data were analysed using conditional logit and fully correlated random parameters logit models. RESULTS: Data from 212 respondents (67 from the Psoriasis Association and 145 from Dynata) were analysed. The signs of all estimated coefficients were consistent with a priori expectations. Respondents had a strong preference for a high predictive accuracy and avoiding serious infection, but there was evidence of systematic differences in preferences between the samples. CONCLUSIONS: This study indicates that individuals with psoriasis would value a biologic calculator and suggested that such a biologic calculator should have sufficient accuracy to predict future response and risk of serious infection from the biologic.
引用
- Dalal G, Wright SJ, Vass CM, et al. Patient preferences for stratified medicine in psoriasis: a discrete choice experiment. Br J Dermatol. 2021. PMID: 33991338. doi:10.1111/bjd.20482
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。